Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Execs On The Move, April 2022 Roundup: Shake Ups At Glaukos, Medtronic, BD And Globus

Executive Summary

Executives On The Move will be running to a monthly schedule from now, with this edition covering medtech's executive changes for April.

You may also be interested in...



Globus Medical Completes First Surgery With Excelsius Imaging System

Globus Medical CFO Keith Pfeil said “enthusiasm is great” with “more than double-digit orders” for the Excelsius3D system.

Meet Embecta! Becton Dickinson Completes Diabetes Spin-Off

Becton Dickinson has formally completed the planned spin-off of its diabetes business within the timeframe it projected about a year ago. The new company, called embecta, is one of the largest producers of diabetes injection devices.

Boston Scientific Makes Half Billion Dollar GI Endosurgery Play

Boston Scientific is greatly increasing its GI endosurgery capabilities with the acquisition of Apollo Endosurgery, a manufacturer of various device for weight loss-related surgeries.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT145369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel